
Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.
Suma Ray, PhD, is a process development scientist, viral clearance and cell line development, Global Purification Technologies Group at Sartorius Stedim Biotech
Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.
How to implement a risk-based approach to eliminate viruses using orthogonal technologies.
How to implement a risk-based approach to eliminating viruses.
Published: March 2nd 2012 | Updated:
Published: October 2nd 2009 | Updated:
Published: September 1st 2008 | Updated: